Application of physiologically based pharmacokinetic modeling in predicting drug-drug interactions for sarpogrelate hydrochloride in humans

about

Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling.

P2860

Q47592224-9C126857-61BB-4468-BB5E-13C6150E5AD6

P2860

Application of physiologically based pharmacokinetic modeling in predicting drug-drug interactions for sarpogrelate hydrochloride in humans

Item

http://www.wikidata.org/entity/Q37265701

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Application of physiologically ...... relate hydrochloride in humans

@en

Application of physiologically ...... elate hydrochloride in humans.

@nl

type

Item

label

Application of physiologically ...... relate hydrochloride in humans

@en

Application of physiologically ...... elate hydrochloride in humans.

@nl

prefLabel

Application of physiologically ...... relate hydrochloride in humans

@en

Application of physiologically ...... elate hydrochloride in humans.

@nl

P1476

Application of physiologically ...... relate hydrochloride in humans

@en

P2093

Doyun Kim

http://www.w3.org/2001/XMLSchema#string

Euichaul Oh

http://www.w3.org/2001/XMLSchema#string

Hyunjin Heo

http://www.w3.org/2001/XMLSchema#string

Jae Hong Seo

http://www.w3.org/2001/XMLSchema#string

Jee Sun Min

http://www.w3.org/2001/XMLSchema#string

Jung Bae Park

http://www.w3.org/2001/XMLSchema#string

Soo Hyeon Bae

http://www.w3.org/2001/XMLSchema#string

Soo Kyung Bae

http://www.w3.org/2001/XMLSchema#string

P2860

Current progress on esterases: from molecular structure to function

Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database

Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity.

Conjunctive effects of the 5HT(2) receptor antagonist, sarpogrelate, on thrombolysis with modified tissue plasminogen activator in different laser-induced thrombosis models.

Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition.

Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects.

Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.

Therapeutic potentials of sarpogrelate in cardiovascular disease.

Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings.

Sarpogrelate: cardiovascular and renal clinical potential.

P304

2959-2972

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S109141

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27695293

http://www.w3.org/2001/XMLSchema#string

P932

5028085

http://www.w3.org/2001/XMLSchema#string

Application of physiologically based pharmacokinetic modeling in predicting drug-drug interactions for sarpogrelate hydrochloride in humans

about

P2860

P2860

Application of physiologically based pharmacokinetic modeling in predicting drug-drug interactions for sarpogrelate hydrochloride in humans

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932